Delivery Order SPE2DE24D0013-SPE2D625F0MGW
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a $4,815 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 7, 2025, with ultimate completion targeted for August 21, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is likely associated with one of Cepheid's existing Indefinite Delivery Vehicle contracts with...
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- The U.S. Defense Department's Medical Supply Chain awarded a $1,930.72 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on May 2, 2025, with an ultimate completion date of May 9, 2025. The contract, designated as XPRSMVP-10, carries no set-aside designation and represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs. Cepheid specializes in...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $2,040 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, under contract XPRS4PLEX-10. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 18, 2025, represents a continuation of Cepheid's ongoing provision of diagnostic solutions to federal healthcare systems. The contract carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The U.S. Defense Department's Medical Supply Chain awarded a $204,000 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 15, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 22, 2025, and carries no set-aside designation. This award represents a continuation of the department's partnership with Cepheid to procure diagnostic testing solutions, specifically for...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on July 10, 2025, with an ultimate completion date of July 17, 2025. The contract, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems, will perform the work at its...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 19, 2025, with an ultimate completion date of September 26, 2025. This delivery order, issued under contract XPRS4PLEX-10, carries no set-aside designation and represents a direct procurement of diagnostic solutions from a leading provider of molecular testing technologies. The award draws from...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $2,097.20 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on May 2, 2025, with an ultimate completion date of May 16, 2025. This firm fixed-price delivery order, designated GXMRSA-NXG-10, carries no set-aside designation and represents a continuation of the federal government's ongoing relationship with Cepheid for diagnostic testing capabilities. The...
- The Defense Department's Medical Supply Chain has awarded a delivery order valued at $2,259.80 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, carries no set-aside designation. The award enables continued procurement of Cepheid's diagnostic solutions, leveraging the company's established expertise in developing and delivering molecular...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0MGWDelivery Order
The U.S. Defense Department's Medical Supply Chain organization awarded Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, a $4,108.25 firm fixed-price delivery order (Contract No. 4569031063) on August 7, 2025, with completion scheduled for August 14, 2025. This delivery order carries no set-aside designation and represents a procurement of diagnostic solutions from Cepheid's established product portfolio. The award leverages Cepheid's expertise in molecular diagnostic systems, including GeneXpert diagnostic equipment, reagents, and test kits designed to detect infectious diseases and support clinical testing operations across federal healthcare systems. This delivery order is likely issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, which represent the company's primary federal contracting vehicles for diagnostic solutions. Cepheid maintains two significant IDV agreements with the VA, including a $32.8 billion single-award contract with Veterans Integrated Service Network 6 extending through September 30, 2030, which provides molecular diagnostic testing system reagents and assays. The company's federal work focuses on delivering diagnostic testing capabilities for conditions including COVID-19, influenza, respiratory syncytial virus, and other infectious diseases critical to military medical readiness and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/7/25 |